Bendamustine as a model for the activity of alkylating agents.
about
A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non-Small Cell Lung Cancer Cells.Bendamustine: a new treatment option for chronic lymphocytic leukemia.Repair of DNA interstrand cross-links during S phase of the mammalian cell cycle.Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.Nucleic acid therapeutics: concepts for targeted delivery to solid tumors
P2860
Bendamustine as a model for the activity of alkylating agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bendamustine as a model for the activity of alkylating agents.
@en
Bendamustine as a model for the activity of alkylating agents.
@nl
type
label
Bendamustine as a model for the activity of alkylating agents.
@en
Bendamustine as a model for the activity of alkylating agents.
@nl
prefLabel
Bendamustine as a model for the activity of alkylating agents.
@en
Bendamustine as a model for the activity of alkylating agents.
@nl
P2093
P2860
P356
P1433
P1476
Bendamustine as a model for the activity of alkylating agents.
@en
P2093
Christos Apostolopoulos
Georgios Giamas
Justin Stebbing
Leandro Castellano
P2860
P304
P356
10.2217/14796694.4.3.323
P407
P577
2008-06-01T00:00:00Z